Resource Filter: Event
Development and optimization of a broad hyperplex immunofuorescence assay for tumor immune microenvironment characterization
Date
Profiling Cytokeratins in the Tumor Microenvironment Using Multiplex Immunofluorescence
Date
Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment
Date
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Date
Spatial Analysis of Tumor Infiltrating Lymphocyte Populations in Syngeneic Mouse Tumor Models After Treatment with IL-12 (mWTX-330) or IL-2 (WTX-124) INDUKINE™ Molecules
Date
Immune Landscape of Adenoid Cystic Carcinoma using Multiplex Immunofluorescence and Digital Pathology
Date
Studying the immune status of the tumor microenvironment with automated hyperplex immunofluorescence
Date
Mapping the spatial heterogeneity of the tumor microenvironment by hyperplex immunofluorescence with COMET™
Date
Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients
Date
Automated multiplex immunofluorescence workflow to interrogate the cellular composition of the tumor microenvironment
Date
